Standardization of Monoclonal Antibodies for Use in Autologous Bone Marrow Transplantation for Common Acute Lymphoblastic Leukemia

References

• Greaves M F, Brown G, Lister A, Rapson N. Antiserum to acute lymphoblastic leukemia cells. Clin Immunol Immunopathol 1975; 4: 67–84
   PubMedGoogle Scholar
• Bernard A, Boumsell L, Hill C. Joint report of the First International Workshop on human leucocyte differentiation antigens by the investigators of the participating laboratories. Leucocyte typing: human leucocyte differentiation antigens detected by monoclonal antibodies, A Bernard, L Boumsell, J Dausset, C Milstein, S F Schlossman. Springer Verlag, Berlin 1984; 9
   Google Scholar
• Anderson K C, Bates M P, Slaughenhoupt B. L., et al. Expression of human B-cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood 1984; 63: 1424–34
   PubMed Web of Science ®Google Scholar
• Kersey J H, Goldman A, Abramson C., et al. The clinical utility of monoclonal antibody phenotyping in childhood acute lymphoblastic leukaemia. Lancet 1982; 2: 1419–23
   PubMed Web of Science ®Google Scholar
• Cornbleet M A, Chessells J M. Bone marrow relapse in acute lymphoblastic leukaemia in childhood. Br Med J 1978; 2: 104–6
   PubMed Web of Science ®Google Scholar
• Johnson F L, Thomas E D, Clark B. S., et al. Comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission. N Engl J Med 1981; 305: 846–51
   PubMed Web of Science ®Google Scholar
• Dicke K A, Jagannath S, Spitzer G., et al. The role of autologous bone marrow transplantation in various malignancies. Semin Hematol 1984; 121: 109–22
   Google Scholar
• Economou J S, Shin H S, Kaiser H., et al. Bone marrow transplantation of cancer therapy: inactivation by antibody and complement of tumor cells in mouse syngeneic marrow transplants. Proc Soc Exp Biol 1978; 158: 449–53
   Google Scholar
• Feeney M, Knapp R C, Greenberger J S, Bast R C. Elimination of leukemic cells from rat bone marrow using antibody and complement. Cancer Res 1981; 41: 3331–5
   PubMed Web of Science ®Google Scholar
• Thierfelder S, Rodt H, Netzel B. Transplantation of syngeneic bone marrow incubated with leucocyte antibodies. I. Suppression of lymphatic leukemia of syngeneic donor mice. Transplantation 1977; 23: 459–63
   Google Scholar
• Netzel B, Haas R J, Rodt H., et al. Immunological conditioning of bone marrow for auto transplantation in childhood acute lymphoblastic leukaemia. Lancet 1980; 1: 1330–2
   PubMed Web of Science ®Google Scholar
• Wells J R, Billing R, Herzog P., et al. Autotransplantation after in-vitro immunotherapy of lymphoblastic leukemia. Exp Hematol 1979; 7((Suppl 5))164–9
   Google Scholar
• Ramsay N, Le Bien T W, Nesbit M., et al. Autologous bone marrow transplantation for acute lymphoblastic leukemia (ALL) following marrow treatment with BA-1, BA-2, BA-3 and rabbit complement. Blood 1983; 62((Suppl 1))228a
   Google Scholar
• Ritz J, Sallan S E, Bast R. C., et al. Autologous bone marrow transplantation in CALLA-positive acute lymphoblastic leukaemia after in-vitro treatment with J5 monoclonal antibody and complement. Lancet 1982; 2: 60–3
   PubMed Web of Science ®Google Scholar
• Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–7
   PubMed Web of Science ®Google Scholar
• Berndt M C, Gregory C, Chong B H. Additional glycoprotein defects in Bernard-Soulier syndrome: confirmation of genetic basis by parental analysis. Blood 1983; 62: 800–7
   PubMed Web of Science ®Google Scholar
• Zola H, Moore M A, McNamara P. J., et al. A membrane protein antigen of platelets and non-T ALL. Disease Markers 1984; 2: 399–417
   Google Scholar
• Pike B L, Robinson A. Human bone marrow colony growth in agargel. J Cell Physiol 1970; 76: 77–84
   PubMed Web of Science ®Google Scholar
• Brooks D A, Bradley J, Zola H. A differentiation antigen expressed electively by a proportion of human blood cells: detection with monoclonal antibody. Pathology 1982; 14: 5–11
   PubMed Web of Science ®Google Scholar
• Ritz J, Pesando J M, Notis-McConarty J, et al. A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature 1980; 283: 583–5
   PubMed Web of Science ®Google Scholar
• Sutherland R, Smart J, Niaudet P, Greaves M F. Acute lymphoblastic leukemia associated antigen. II. Isolation and partial characterization. Leuk Res 1978; 2: 115–26
   Google Scholar
• LeBien T W, Boue D R, Bradley J G, Kersey J H. Antibody affinity may influence antigenic modulation of the common acute lymphoblastic leukemia antigen in vitro. J Immunol 1982; 120: 2287–92
   Google Scholar
• Pesando J M, Ritz J, Lazarus H, et al. Fate of a common acute lymphoblastic leukemia antigen during modulation by monoclonal antibody. J Immunol 1981; 236: 540–4
   Google Scholar
• Bast R C, Ritz J, Lipton J. M., et al. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement. Cancer Res 1983; 43: 1389–94
   PubMed Web of Science ®Google Scholar
• Le Bien T W, Ash R C, Zanjani E D, Kersey J H. In vitro cytodestruction of leukemia cells in human bone marrow using a cocktail of monoclonal antibodies. Modern trends in human leukemia V, R Neth, R C Gallo, M F Greaves, M AS Moore, K Winkler. Springer-Verlag, New York 1983; 112–6
   Google Scholar
• Jansen J, Falkenberg J HF, Stepan D E, Le Bien T W. Removal of neoplastic cells from autologus bone marrow grafts with monoclonal antibodies. Semin Hematol 1984; 21: 164–81
   PubMed Web of Science ®Google Scholar
• Ash R C, Jansen J, Kersey J. H., et al. Normal human pluripotential and committed hematopoietic progenitors do not express the p24 antigen detected by monoclonal antibody BA-2: implications for immunotherapy of lymphocytic leukemia. Blood 1982; 60: 1310–6
   PubMed Web of Science ®Google Scholar
• Clavell L A, Lipton J M, Bast R. C., et al. Absence of common ALL antigen on normal bipotent myeloid erythroid and granulocyte progenitors. Blood 1981; 58: 333–6
   Google Scholar
• Moolten F L, Schreiber B M, Zajdel S H. Antibodies conjugated to potent cytotoxins as specific antitumour agents. Immunol Rev 1982; 62: 47–73
   PubMed Web of Science ®Google Scholar
• Treleaven J G, Gibson F M, Ugelstadt J., et al. Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet 1984; 1: 70–73
   PubMed Web of Science ®Google Scholar